These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33151962)

  • 1. Algorithmic assessment of missense mutation severity in the Von-Hippel Lindau protein.
    Fields FR; Suresh N; Hiller M; Freed SD; Haldar K; Lee SW
    PLoS One; 2020; 15(11):e0234100. PubMed ID: 33151962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Hippel-Lindau disease: a clinical and scientific review.
    Maher ER; Neumann HP; Richard S
    Eur J Hum Genet; 2011 Jun; 19(6):617-23. PubMed ID: 21386872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype and phenotype correlation in von Hippel-Lindau disease based on alteration of the HIF-α binding site in VHL protein.
    Liu SJ; Wang JY; Peng SH; Li T; Ning XH; Hong BA; Liu JY; Wu PJ; Zhou BW; Zhou JC; Qi NN; Peng X; Zhang JF; Ma KF; Cai L; Gong K
    Genet Med; 2018 Oct; 20(10):1266-1273. PubMed ID: 29595810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.
    Clifford SC; Cockman ME; Smallwood AC; Mole DR; Woodward ER; Maxwell PH; Ratcliffe PJ; Maher ER
    Hum Mol Genet; 2001 May; 10(10):1029-38. PubMed ID: 11331613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
    Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
    Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease.
    Tirosh A; El Lakis M; Green P; Nockel P; Patel D; Nilubol N; Gara SK; Keutgen XM; Linehan WM; Kebebew E
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1631-1638. PubMed ID: 29294023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HIF and other quandaries in VHL disease.
    Tarade D; Ohh M
    Oncogene; 2018 Jan; 37(2):139-147. PubMed ID: 28925400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts.
    Cingoz S; van der Luijt RB; Kurt E; Apaydin M; Akkol I; Ozgen MH
    Fam Cancer; 2013 Mar; 12(1):111-7. PubMed ID: 23224817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
    Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
    BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Hippel-Lindau disease: a single gene, several hereditary tumors.
    Crespigio J; Berbel LCL; Dias MA; Berbel RF; Pereira SS; Pignatelli D; Mazzuco TL
    J Endocrinol Invest; 2018 Jan; 41(1):21-31. PubMed ID: 28589383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Hippel-Lindau syndrome.
    Chou A; Toon C; Pickett J; Gill AJ
    Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer].
    Moch H
    Pathologe; 2008 Nov; 29 Suppl 2():149-52. PubMed ID: 18751708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones.
    Tsuchiya MI; Okuda H; Takaki Y; Baba M; Hirai S; Ohno S; Shuin T
    Oncol Rep; 2005 Jun; 13(6):1033-41. PubMed ID: 15870918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
    Wittström E; Nordling M; Andréasson S
    Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing.
    Kaelin WG
    Cold Spring Harb Symp Quant Biol; 2005; 70():159-66. PubMed ID: 16869749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance.
    Razafinjatovo C; Bihr S; Mischo A; Vogl U; Schmidinger M; Moch H; Schraml P
    BMC Cancer; 2016 Aug; 16():638. PubMed ID: 27530247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intronic mutation of the VHL gene associated with central nervous system hemangioblastomas in two Chinese families with Von Hippel-Lindau disease: case report.
    Liu Z; Zhou J; Li L; Yi Z; Lu R; Li C; Gong K
    BMC Med Genet; 2020 Oct; 21(1):191. PubMed ID: 33004005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
    Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
    Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.